PT - JOURNAL ARTICLE AU - Bronwyn J. Overs AU - Gloria Roberts AU - Kate Ridgway AU - Claudio Toma AU - Dusan Hadzi-Pavlovic AU - Holly C. Wilcox AU - Leslie A. Hulvershorn AU - John I. Nurnberger AU - Peter R. Schofield AU - Philip B. Mitchell AU - Janice M. Fullerton TI - Effects of polygenic risk for suicide attempt and risky behavior on brain structure in young people with familial risk of bipolar disorder AID - 10.1101/2021.09.06.21262817 DP - 2021 Jan 01 TA - medRxiv PG - 2021.09.06.21262817 4099 - http://medrxiv.org/content/early/2021/09/21/2021.09.06.21262817.short 4100 - http://medrxiv.org/content/early/2021/09/21/2021.09.06.21262817.full AB - Aims Bipolar Disorder (BD) is associated with a 20-30 fold increased suicide risk compared to the general population. First-degree relatives of BD patients show inflated rates of psychopathology including suicidal behaviors. As reliable biomarkers of suicide attempts (SA) are lacking, we examined associations between suicide-related polygenic risk scores (PRS) – a quantitative index of genomic risk – and variability in brain structures implicated in SA.Methods Participants (n=206; aged 12-30 years) were unrelated individuals of European ancestry and comprised three groups: 41 BD cases, 96 BD relatives (‘high-risk’), and 69 controls. Genotyping employed PsychArray, followed by imputation. Three PRS were computed using genome-wide association data for SA in BD (SA-in-BD), SA in Major Depressive Disorder (SA-in-MDD) [Mullins et al., 2019], and risky behavior [Karlsson Linnér et al., 2019]. Structural MRI processing employed FreeSurfer v5.3.0. General linear models were constructed using 32 regions-of-interest identified from suicide neuroimaging literature, with false-discovery-rate correction.Results SA-in-MDD and SA-in-BD PRS negatively predicted parahippocampal thickness, with the latter association modified by group membership. SA-in-BD and Risky Behavior PRS inversely predicted rostral and caudal anterior cingulate structure, respectively, with the latter effect driven by the ‘high-risk’ group. SA-in-MDD and SA-in-BD PRS positively predicted cuneus structure, irrespective of group.Conclusions This study demonstrated associations between PRS for suicide-related phenotypes and structural variability in brain regions implicated in SA. Future exploration of extended PRS, in conjunction with a range of biological, phenotypic, environmental and experiential data in high-risk populations, may inform predictive models for suicidal behaviors.Competing Interest StatementJohn I. Nurnberger, MD is an investigator for Janssen, with interests unrelated to the current work. All other authors have no potential or perceived conflicts of interest to declare.Funding StatementThis work was supported by the Australian National Health and Medical Research Council (NHMRC) Project Grant 1066177 (JMF, RKL, JIN), Program Grant 1037196 (PBM, PRS) and Investigator Grants 1176716 (PRS) and 1177991 (PBM), and philanthropic support from the Lansdowne Foundation, Paul and Jenny Reid, Good Talk and the Keith Pettigrew Family Bequest. DNA extraction was undertaken by Genetic Repositories Australia (GRA; www.neura.edu.au/GRA), a national genetic repository with funding provided by NHMRC Enabling Grant 401184. JMF gratefully acknowledges the Janette Mary O'Neil Research Fellowship in support of this work. CT is a recipient of a 'Ramón y Cajal' fellowship (RYC2018-024106-I) from the Spanish MINECO.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Ethical approval to conduct this study was provided by the University of New South Wales Human Research Ethics Committee (HREC Protocol 09/097).All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe data that support the findings of this study are available in the UNSW data archive ResData at www.dataarchive.unsw.edu.au, under Research Data Management Plan reference number D0237303, or are available on request from the authors.